 | ||||||||
| "anti diabetes" | ||||||||
| NEWS | ||||||||
Merck & Co and NGM Biopharmaceuticals team to take on obesity and diabetes The anti-diabetes drug industry was worth $35.6bn in 2012 and is predicted to increase in value to $55.3bn in 2017. Whilst being closely related to ...
| ||||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.